AMCP 2017

The AMCP Managed Care & Specialty Pharmacy Annual Meeting, held March 27-30, in Denver, Colorado, will bring into focus the ingrained and expanding role of specialty pharmacy and provide up-to-date information on legislation and regulation, research, and formulary management. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage.

Coverage

Dr Jennifer Graff Discusses the Importance of Patient-Reported Outcomes
   |    AMCP
Patient-reported outcomes influence what is considered to be high-value care in the healthcare system, according to Jennifer Graff, PharmD, vice president of comparative effectiveness research at the National Pharmaceutical Council.
Dr Jennifer Graff on How Payers Make Decisions
   |    AMCP
Jennifer Graff, PharmD, vice president of comparative effectiveness research at the National Pharmaceutical Council, discusses where payers receive their information and how it is used to make decisions about coverage and reimbursement.
Laura Topor Discusses Challenges of e-Prescribing Specialty Medications
   |    AMCP
Prescribers and pharmacies can encounter some unique challenges when specialty drugs are e-prescribed, but organizations like the National Council for Prescription Drug Programs are trying to make the process smoother, explained Laura Topor, president of Granada Health.
Dr Jacqueline Glover: Financial Knowledge Is Part of Informed Consent
   |    AMCP
Informed consent is one of the principal values in healthcare, but it should include discussions about cost, said Jacqueline Glover, PhD, professor in the Department of Pediatrics and the Center for Bioethics and Humanities at the University of Colorado Denver. Glover also discussed the need to clarify the language surrounding end-of-life care.
Laura Topor Explains the Value of Real-Time Benefit Transactions
   |    AMCP
Real-time prescription benefit transactions are designed to give clinicians essential information on an individual patient’s benefits before writing a prescription, according to Laura Topor, president of Granada Health.
Dr Jacqueline Glover: Clinicians' Obligations of Justice Regarding Costs of Care
   |    AMCP
Clinicians have obligations of justice when treating patients, which can lead to difficult decisions on how to ethically allocate limited resources to patients as a whole, said Jacqueline Glover, PhD, professor in the Department of Pediatrics and the Center for Bioethics and Humanities at the University of Colorado Denver.
Dr Lou Garrison Discusses Challenges of Working With Real-World Data
   |    AMCP
Working with real-world evidence-based data can pose difficulties, both when collecting and analyzing the information, but redesigned incentives could help drive entities to provide more information, said Lou Garrison, PhD, professor emeritus in the Department of Pharmacy, University of Washington.
Dr Neil Minkoff Explains How 340B Impacts Pharmacies and Payers Differently
   |    AMCP
All stakeholders stand to gain from the 340B program in different ways, but they also take on different risks, like the potential impact for health plans on rebate contracts, said Neil Minkoff, MD, chief medical officer of EmpiraMed.
Compendia
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Upcoming Partner Events
October 16-17, 2017
Washington, D.C.
October 24-25, 2017
San Francisco, CA
$vacMongoViewPlus$